Multiple variables impact prostate and breast cancer incidence, including genetic heredity as well as environmental and societal influences.
Melanoma News
Swedish Melanoma Detection Device To Be Piloted at Dallas-Area Bare Dermatology Clinics
Doctors can often identify signs of a melanoma through a visual examination of a patient’s skin, by using a dermoscope or other tools.
Detecting Melanoma Copy Number Variation: Novel CDKN2A Quantitation Using Droplet Digital PCR
Doctors can often identify signs of a melanoma through a visual examination of a patient’s skin, by using a dermoscope or other tools. But additional information is sometimes needed to make a precise diagnosis, according to SciBase, a medical tech company based in Stockholm, Sweden—which has developed a device it says provides exactly that.
FDA Approves Melphalan Hepatic Delivery System for Adult Patients With Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
On August 14, the U.S. Food and Drug Administration (FDA) approved the HEPZATO KIT, a melphalan hepatic delivery system, as a liver-directed treatment for adult patients with metastatic uveal melanoma and unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.